Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1996 2
1997 4
1999 2
2000 2
2001 4
2002 7
2003 8
2004 9
2005 8
2006 17
2007 20
2008 34
2009 35
2010 35
2011 41
2012 38
2013 32
2014 37
2015 51
2016 38
2017 47
2018 36
2019 37
2020 60
2021 79
2022 61
2023 55
2024 40
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

762 results

Results by year

Filters applied: . Clear all
Page 1
Monkeypox.
Gessain A, Nakoune E, Yazdanpanah Y. Gessain A, et al. Among authors: yazdanpanah y. N Engl J Med. 2022 Nov 10;387(19):1783-1793. doi: 10.1056/NEJMra2208860. Epub 2022 Oct 26. N Engl J Med. 2022. PMID: 36286263 Review. No abstract available.
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy.
Orkin C, Antinori A, Rockstroh JK, Moreno-Guillén S, Martorell CT, Molina JM, Lazzarin A, Maggiolo F, Yazdanpanah Y, Andreatta K, Huang H, Hindman JT, Martin H, Pozniak A. Orkin C, et al. Among authors: yazdanpanah y. AIDS. 2024 Jun 1;38(7):983-991. doi: 10.1097/QAD.0000000000003865. Epub 2024 Feb 21. AIDS. 2024. PMID: 38349226 Free PMC article. Clinical Trial.
Monkeypox. Reply.
Gessain A, Nakoune E, Yazdanpanah Y. Gessain A, et al. Among authors: yazdanpanah y. N Engl J Med. 2023 Feb 16;388(7):671. doi: 10.1056/NEJMc2215751. N Engl J Med. 2023. PMID: 36791180 No abstract available.
Reply.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y. Cousien A, et al. Among authors: yazdanpanah y. Hepatology. 2017 Jun;65(6):2129-2130. doi: 10.1002/hep.29069. Epub 2017 Apr 18. Hepatology. 2017. PMID: 28108986 No abstract available.
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM; GS-US-200-4625 investigators. Ogbuagu O, et al. Among authors: yazdanpanah y. Lancet HIV. 2023 Aug;10(8):e497-e505. doi: 10.1016/S2352-3018(23)00113-3. Epub 2023 Jul 11. Lancet HIV. 2023. PMID: 37451297 Clinical Trial.
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D; GS-US-380-1489 and GS-US-380-1490 study investigators. Sax PE, et al. Among authors: yazdanpanah y. EClinicalMedicine. 2023 May 11;59:101991. doi: 10.1016/j.eclinm.2023.101991. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37200995 Free PMC article.
Reply.
Cousien A, Deuffic-Burban S, Yazdanpanah Y. Cousien A, et al. Among authors: yazdanpanah y. Hepatology. 2016 Sep;64(3):1004-6. doi: 10.1002/hep.28447. Epub 2016 Mar 7. Hepatology. 2016. PMID: 26754690 No abstract available.
COVID-19 vaccines: A race against time.
Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P. Peiffer-Smadja N, et al. Among authors: yazdanpanah y. Anaesth Crit Care Pain Med. 2021 Apr;40(2):100848. doi: 10.1016/j.accpm.2021.100848. Epub 2021 Mar 24. Anaesth Crit Care Pain Med. 2021. PMID: 33774261 Free PMC article. No abstract available.
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
Smadja DM, Massonnaud CR, Philippe A, Rosa M, Luneau S, Rauch A, Peiffer-Smadja N, Gagneux-Brunon A, Poissy J, Gruest M, Ung A, Pourcher V, Raffi F, Piroth L, Bouiller K, Esperou H, Delmas C, Belhadi D, Diallo A, Saillard J, Dechanet A, Mercier N, Dupont A, Lescure FX, Goehringer F, Jaureguiberry S, Danion F, Tolsma V, Cabie A, Courjon J, Leroy S, Mootien J, Mourvillier B, Gallien S, Lanoix JP, Botelho-Nevers E, Wallet F, Richard JC, Reuter J, Gaymard A, Greil R, Martin-Blondel G, Andrejak C, Yazdanpanah Y, Burdet C, Diehl JL, Hites M, Ader F, Susen S, Mentré F, Dupont A; Discovery Study Group. Smadja DM, et al. Among authors: yazdanpanah y. Sci Rep. 2025 Apr 24;15(1):14348. doi: 10.1038/s41598-025-95122-7. Sci Rep. 2025. PMID: 40274842 Free PMC article. Clinical Trial.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Among authors: yazdanpanah y. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
762 results